| Cash Flow | 2025-06-30 |
|---|---|
| Stock-based compensation | 6,319,378 |
| Convertible note payable for non-cash issuance costs | 0 |
| Change in right-of-use lease asset | 267,952 |
| Net loss | -83,618,591 |
| Prepaid expenses and other current assets | -1,318,444 |
| Other noncurrent assets | -103,204 |
| Other current liabilities | -767,707 |
| Operating lease liabilities | -275,614 |
| Inventory | 946,052 |
| Accrued expenses | -507,883 |
| Accounts receivable | -89,048 |
| Accounts payable | 1,106,878 |
| Loss on disposal of property and equipment | 0 |
| Depreciation | 678,959 |
| Change in deferred taxes | 285 |
| Shares issued for non-cash consultant expense | 673,497 |
| Non-cash lease income | 22,064 |
| Non cash interest income on note receivable | 363,798 |
| Receivable from noncontrolling interest | -28,353 |
| Change in fair value of share liability | -129,269 |
| Change in fair value of convertible notes payable | -64,715,131 |
| Net cash used in operating activities | -11,071,311 |
| Purchases of property and equipment | 4,107,564 |
| Cash advance in exchanges for note receivable | 30,000,000 |
| Net cash used in investing activities | -34,107,564 |
| Payment of notes payable | 409,696 |
| Payment of principal portion of bank loans | 392,263 |
| Proceeds from exercise of warrants | 4,915,312 |
| Proceeds from issuance of common stock | 50,000,000 |
| Proceeds from issuance of convertible notes payable | 0 |
| Proceeds from bank loans | 47,045 |
| Payment of common stock issuance costs | 3,238,630 |
| Payment of principal portion of finance leases | 61,831 |
| Distribution to noncontrolling interest in vie | 79,310 |
| Proceeds from noncontrolling interest in vie | 0 |
| Proceeds from collection of receivable from noncontrolling interest in vie | 0 |
| Net cash provided by financing activities | 50,780,627 |
| Net change in cash and cash equivalents | 5,601,752 |
ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. (ASPI)